Targeting Epac2 and GluA3-containing AMPARs: a novel therapeutic strategy for Alzheimer's disease

Neural Regen Res. 2025 Nov 1;20(11):3223-3224. doi: 10.4103/NRR.NRR-D-24-00751. Epub 2024 Oct 22.
No abstract available